Design and synthesis of nonpeptide angiotensin II receptor antagonists featuring acyclic imidazole-mimicking structural units.

Extensive molecular modelling studies, including conformational analysis and the comparison of molecular electrostatic potential distributions, wee used to evaluate structural parameters of new antagonists containing acyclic replacements of the N = C-N imidazole region. The synthesis and the biological screening of a series of acyl biphenyltetrazole derivatives were planned and realized to gain an insight into the structure-activity relationships of this unusual class of Angiotensin II antagonists.

[1]  Carlo Scolastico,et al.  A 3D QSAR CoMFA study of non-peptide angiotensin II receptor antagonists , 1996, J. Comput. Aided Mol. Des..

[2]  Anna Vulpetti,et al.  On the role of the molecular electrostatic potential in modelling the activity of non-peptide angiotensin II receptor antagonists , 1993 .

[3]  M. Hartmann.  Molecular mechanics. Von ULRICH BURKERT und NORMAN L. ALLINGER. ACS Monograph 177. Washington: American Chemical Society 1982. 430 S., US $ 77.95 , 1984 .

[4]  Roberto Todeschini,et al.  Linear discriminant classification tree: A user-driven multicriteria classification method , 1992 .

[5]  W. Price,et al.  Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensives. , 1991, Journal of medicinal chemistry.

[6]  L. Belvisi,et al.  N-3-substituted pyrimidinones as potent, orally active, AT1 selective angiotensin II receptor antagonists. , 1995, Journal of medicinal chemistry.

[7]  G. Chang,et al.  Macromodel—an integrated software system for modeling organic and bioorganic molecules using molecular mechanics , 1990 .

[8]  Y. Christen,et al.  Oral Administration of DuP 753, a Specific Angiotensin II Receptor Antagonist, to Normal Male Volunteers: Inhibition of Pressor Response to Exogenous Angiotensin I and II , 1991, Circulation.

[9]  M. Jung,et al.  Simple syntheses of diethyl oxomalonate and alkyl glyoxylates , 1982 .

[10]  W. Emmons,et al.  The Utility of Phosphonate Carbanions in Olefin Synthesis , 1961 .

[11]  J. Ponder,et al.  An efficient newton‐like method for molecular mechanics energy minimization of large molecules , 1987 .

[12]  M. Vallotton,et al.  The renin-angiotensin system , 1987 .

[13]  Steven Whitebread,et al.  Valsartan, a potent, orally active angiotensin II antagonist developed from the structurally new amino acid series , 1994 .

[14]  A. Subissi,et al.  Pharmacology of LR‐B/081, a new highly potent, selective and orally active, nonpeptide angiotensin II AT1 receptor antagonist , 1995, British journal of pharmacology.

[15]  Roberto Todeschini,et al.  A 3D QSAR approach to the search for geometrical similarity in a series of nonpeptide angiotensin II receptor antagonists , 1994, J. Comput. Aided Mol. Des..

[16]  B. Feringa,et al.  Synthesis of enantiomerically pure γ-(menthyloxy)butenolides and (R)- and (S)-2-methyl-1,4-butanediol , 1989 .

[17]  G. Chang,et al.  An internal-coordinate Monte Carlo method for searching conformational space , 1989 .

[18]  G. Bravi,et al.  Nonpeptide angiotensin II receptor antagonists. Synthesis, in vitro activity, and molecular modeling studies of N-[(heterobiaryl)methyl] imidazoles. , 1994, Journal of medicinal chemistry.